Preface

There are seven chapters in this book entitled " Drug Repurposing against SARS-CoV2." The book focuses on current trends in drug repurposing against SARS-CoV2.

The goal of this book is to give readers an overview of drug repurposing in life-threating diseases, drug repurposing in COVID-19, as well as various techniques involved in drug repurposing. The book aims to target students, research scholars, and physicians interested in the topic. The book's structure is well-organized and updated.

Chapter 1 by Ruchi Chawla discusses repurposing drugs: a new paradigm and hopes for life-threatening diseases.

Anand et al., in Chapter 2, outline the repurposed and adjuvant drugs in COVID-19 patients, as well as challenges and ethical issues related to drug repurposing. Chapter 3 by Neelam et al. presents the repurposed drugs against SARS-CoV-2 replication in COVID-19. In Chapter 4, Awesh Yadav et al., describe the targeting of viral entry pathways through repurposed drugs in SARS-CoV-2 infection.

Repurposed drugs or potential pharmacological agents targeting cytokine release, and induction of coagulation in COVID-19 are discussed in Chapter 5 by Arpita Singh et al. In Chapter 6, Qidwai et al., discuss the High-throughput screening (HTS) method for screening of known drugs. The last chapter by Khan et al., discusses drug repurposing for COVID-19 using computational methods.

I believe this book will be of tremendous interest to students, doctors, researchers, and even patients and their families. Finally, I would like to express my gratitude to all of the contributors to this book, as well as the Bentham Publishing Editorial Board for providing us with this invaluable opportunity.